title: Editorial comment.
authors.affiliation: Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.
authors.forename: Terhi
authors.initials: T
authors.lastname: Hermanson
authors.affiliation: University of Arizona College of Medicine, Tucson, AZ.
authors.forename: Oliver
authors.initials: O
authors.lastname: Sartor
authors.affiliation: Tulane University School of Medicine, New Orleans, LA.
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Ablin
authors.affiliation: The Southern Network on Adverse Reaction (SONAR) project, the South Carolina Center of Economic Excellence for Medication Safety, the South Carolina College of Pharmacy, University of South Carolina, Columbia, SC; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.
authors.forename: Charles L
authors.initials: CL
authors.lastname: Bennett
mesh_terms: D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000601:surgery* / Q000628:therapy*